5 results
The main objective of this study is to test the effects of combined SGLT1 and SGLT2 inhibition with sotagliflozin on hemoconcentration and plasma volume in patients with heart failure.
Primary:Does the implementation of a Parietene® self-fixing semi-resorbable mesh (Covidien-Sofradim) result in less chronic inguinal pain as compared to a standard polypropylene mesh (Marlex®; Bard) in the treatment of a inguinal hernia using the…
The main objectives of the study are to demonstrate whether sotagliflozin reduces the composite of CV (cardiovascular) death and HHF (hospitalization for heart failure) as compared to placebo in diabetic patients after admission for WHF (worsening…
This study is designed to demonstrate the CV and renal effects of sotagliflozin in patients with T2D, high CV risk, and moderate renal impairment. One of the major objectives of this study is to fulfill the regulatory mandate that any new therapy…
· To evaluate the effect of zibotentan anddapagliflozin in combination and alone versusplacebo on UACR.